Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Corporate Reputation of Pharma Companies, 2016-2017 Perspective of 75 Italian Patient Groups (2017 Edition) - Research and Markets

Research and Markets
Posted on: 27 Oct 17

The "The Corporate Reputation of Pharma Companies, 2016: from the Perspective of 75 Italian Patient Groups (3rd Edition)" report has been added to Research and Markets' offering.

These results are derived from a global review of pharma's corporate reputation (conducted November 2016 to early-February 2017).

These results are based on the opinions of 75 Italian patient groups (17 specialised in cancer; 10 in diabetes; 6 in HIV/AIDS; and other specialties).

16 pharma companies are included in this 2016 Italian analysis:

  • AbbVie
  • AstraZeneca
  • Bayer
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Eli Lilly (Lilly)
  • GSK
  • Janssen (Pharmaceutical companies of Johnson & Johnson)
  • Menarini
  • Merck & Co
  • Novartis
  • Pfizer
  • Roche
  • Sandoz
  • Sanofi
  • Teva

The 16 companies were chosen because a minimum of 19 Italian patient groups declared familiarity with each one.

In response to a survey of pharmaceutical companies, Eisai provided information on its patient centricity and its relations with patient-advocacy groups during 2016-2017 in Italy.


Industry-wide questions:

  • How the pharma industry's corporate reputation compares with that of other healthcare industries.
  • How the pharma industry's corporate reputation has changed over the past five years.
  • How good or bad the pharma industry is at various activities of relevance to patients and patient groups.

7 indicators show the corporate reputation of individual pharma companies:

  • Patient centricity.
  • Information for patients.
  • Patient safety.
  • Usefulness of products.
  • Transparency.
  • Integrity.
  • Patient-group relationships (new for 2016).

For more information about this report visit

View source version on

Business Wire

Last updated on: 27/10/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.